These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 9558683)
1. Effects of procainamide on the excitable gap composition in common human atrial flutter. Jalil E; Le Franc P; Lebeau R; Molin F; Costi P; Kús T Pacing Clin Electrophysiol; 1998 Mar; 21(3):528-35. PubMed ID: 9558683 [TBL] [Abstract][Full Text] [Related]
2. Effects of procainamide on the excitable gap composition in a canine model of atrial flutter. Jalil E; Laflamme M; Kus T Can J Physiol Pharmacol; 1997 Jan; 75(1):1-8. PubMed ID: 9101058 [TBL] [Abstract][Full Text] [Related]
3. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia. Derakhchan K; Pagé P; Lambert C; Kus T J Pharmacol Exp Ther; 1994 Jul; 270(1):47-54. PubMed ID: 8035342 [TBL] [Abstract][Full Text] [Related]
4. Effects of procainamide on refractoriness, conduction, and excitable gap in canine atrial reentrant tachycardia. Kus T; Derakhchan K; Bouchard C; Pagé P Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1707-13. PubMed ID: 1721162 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit. Stambler BS; Wood MA; Ellenbogen KA J Am Coll Cardiol; 1996 Feb; 27(2):453-61. PubMed ID: 8557920 [TBL] [Abstract][Full Text] [Related]
6. Excitable gap composition in the presence of antiarrhythmic drugs in common human atrial flutter. Jalil E; Mensour B; Vinet A; Kus T Can J Cardiol; 2003 Mar; 19(3):244-8. PubMed ID: 12677279 [TBL] [Abstract][Full Text] [Related]
7. Effect of chronic amiodarone therapy on excitable gap during typical human atrial flutter. Maury P; Zimmermann M J Cardiovasc Electrophysiol; 2004 Dec; 15(12):1416-23. PubMed ID: 15610289 [TBL] [Abstract][Full Text] [Related]
8. Influence of propafenone on resetting and termination of canine atrial flutter. Mensour B; Jalil E; Vinet A; Kus T Pacing Clin Electrophysiol; 2000 Aug; 23(8):1200-19. PubMed ID: 10962741 [TBL] [Abstract][Full Text] [Related]
9. Characterization of low right atrial isthmus as the slow conduction zone and pharmacological target in typical atrial flutter. Tai CT; Chen SA; Chiang CE; Lee SH; Ueng KC; Wen ZC; Huang JL; Chen YJ; Yu WC; Feng AN; Chiou CW; Chang MS Circulation; 1997 Oct; 96(8):2601-11. PubMed ID: 9355900 [TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy. Stambler BS; Wood MA; Ellenbogen KA Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896 [TBL] [Abstract][Full Text] [Related]
11. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap. Inoue H; Yamashita T; Nozaki A; Sugimoto T J Am Coll Cardiol; 1991 Oct; 18(4):1098-104. PubMed ID: 1910060 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the excitable gap in a functionally determined reentrant circuit. Studies in the sterile pericarditis model of atrial flutter. Niwano S; Ortiz J; Abe H; Gonzalez X; Rudy Y; Waldo AL Circulation; 1994 Oct; 90(4):1997-2014. PubMed ID: 7522990 [TBL] [Abstract][Full Text] [Related]
13. Effect of procainamide and N-acetylprocainamide on atrial flutter: studies in vivo and in vitro. Wu KM; Hoffman BF Circulation; 1987 Dec; 76(6):1397-408. PubMed ID: 2445503 [TBL] [Abstract][Full Text] [Related]
14. Circus movement atrial flutter in the canine sterile pericarditis model. Differential effects of procainamide on the components of the reentrant pathway. Schoels W; Yang H; Gough WB; el-Sherif N Circ Res; 1991 Apr; 68(4):1117-26. PubMed ID: 2009611 [TBL] [Abstract][Full Text] [Related]
15. Effect of autonomic neurotransmitters on excitable gap composition in canine atrial flutter. Rahme MM; Jalil E; Laflamme M; Kus T Can J Physiol Pharmacol; 2001 Jan; 79(1):13-7. PubMed ID: 11201496 [TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing. Stambler BS; Wood MA; Ellenbogen KA Am J Cardiol; 1996 May; 77(11):960-6. PubMed ID: 8644646 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic mechanism of typical atrial flutter termination by nifekalant: effect of a pure IKr -selective blocking agent. Yamabe H; Tanaka Y; Morihisa K; Uemura T; Koyama J; Kanazawa H; Hoshiyama T; Ogawa H Pacing Clin Electrophysiol; 2013 Sep; 36(9):1123-31. PubMed ID: 23607491 [TBL] [Abstract][Full Text] [Related]
18. Sustained atrial flutter around the tricuspid valve in pigs: differentiation of procainamide (class IA) from flecainide (class IC) and their rate-dependent effects. Crijns HJ; de Langen CD; Grandjean JG; Bel KJ; Ebels T; Lie KI; Wesseling H J Cardiovasc Pharmacol; 1993 Mar; 21(3):462-70. PubMed ID: 7681509 [TBL] [Abstract][Full Text] [Related]
19. Transitions among atrial fibrillation, atrial flutter, and sinus rhythm during procainamide infusion and vagal stimulation in dogs with sterile pericarditis. Pagé PL; Hassanalizadeh H; Cardinal R Can J Physiol Pharmacol; 1991 Jan; 69(1):15-24. PubMed ID: 2036596 [TBL] [Abstract][Full Text] [Related]
20. Effects of disopyramide on cycle length, effective refractory period and excitable gap of atrial flutter, and relation to arrhythmia termination by overdrive pacing. Della Bella P; Marenzi G; Tondo C; Doni F; Lauri G; Grazi S; Guazzi MD Am J Cardiol; 1989 Apr; 63(12):812-6. PubMed ID: 2929438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]